Fabric Genomics to Co-market Comprehensive Sample-to-Genomic Analysis Sequencing Solutions for Hereditary Genetics
Summary
Clinical research labs that are expanding assay menus will benefit from reduced costs of development and faster validation. “Clinical research labs have a need to take a collected sample from library prep quickly, all the way through to analysis, and our agreement with Roche demonstrates our commitment to supporting these critical workflows,” said Martin Reese, PhD, co-founder and CEO of Fabric Genomics. “Using our Fabric Enterprise analysis platform with Roche KAPA HyperExome Probes ensures high coverage of disease-causing genes, which is of the utmost importance in accelerating the identification of rare variants. Combining these technologies into a single workflow will lead to higher quality results and increased reliability of sequencing-based diagnostics in routine care. With widespread adoption of sequencing technology innovation, we can further our shared goal of improving personalized care.” KAPA products are for research use only (RUO).
Classifications
AskAI Classifications
LabelsLinked Companies
